We are live on ! Find out more
VPC

Vestal Point Capital Portfolio holdings

AUM $3.58B
1-Year Est. Return 190.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+190.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.58B
AUM Growth
+$851M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
113
New
Increased
Reduced
Closed

Top Buys

1
+$210M
2
+$166M
3
+$118M
4
ARWR icon
Arrowhead Research
ARWR
+$87M
5
IMCR icon
Immunocore
IMCR
+$70.6M

Top Sells

1
+$191M
2
+$144M
3
+$84.6M
4
MRK icon
Merck
MRK
+$81.6M
5
TYRA icon
Tyra Biosciences
TYRA
+$76.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVL icon
26
Nuvalent
NUVL
$9.75B
$49.4M 1.38%
481,715
+435,715
COGT icon
27
Cogent Biosciences
COGT
$5.66B
$47.4M 1.32%
+1,230,888
ANRO icon
28
Alto Neuroscience
ANRO
$753M
$46.4M 1.3%
2,064,075
-420,925
RAPP
29
Rapport Therapeutics
RAPP
$1.84B
$44.9M 1.26%
1,436,229
+326,229
IRON icon
30
Disc Medicine
IRON
$2.6B
$44.8M 1.25%
700,000
-35,000
UTHR icon
31
United Therapeutics
UTHR
$23.2B
$44.5M 1.24%
+75,000
CLDX icon
32
Celldex Therapeutics
CLDX
$2.45B
$38.8M 1.09%
1,224,165
+59,165
KALV icon
33
KalVista Pharmaceuticals
KALV
$37.2M 1.04%
1,850,000
-40,000
XENE icon
34
Xenon Pharmaceuticals
XENE
$5.04B
$37.2M 1.04%
639,900
+39,900
SLDB icon
35
Solid Biosciences
SLDB
$703M
$36M 1.01%
5,000,000
-815,000
DRUG
36
Bright Minds Biosciences
DRUG
$598M
$35.9M 1%
+492,319
PTGX icon
37
Protagonist Therapeutics
PTGX
$7.06B
$34.4M 0.96%
+326,159
DNLI icon
38
Denali Therapeutics
DNLI
$3.44B
$34M 0.95%
1,773,326
+1,308,326
REGN icon
39
Regeneron Pharmaceuticals
REGN
$64.2B
$30.9M 0.86%
+40,000
WAT icon
40
Waters Corp
WAT
$34.9B
$29.8M 0.83%
+100,000
VKTX icon
41
Viking Therapeutics
VKTX
$3.34B
$29.7M 0.83%
+914,147
INSP icon
42
Inspire Medical Systems
INSP
$1.23B
$27.8M 0.78%
+539,269
CBIO
43
Crescent Biopharma
CBIO
$494M
$27.6M 0.77%
1,500,000
TRVI icon
44
Trevi Therapeutics
TRVI
$2.02B
$25.8M 0.72%
+2,166,504
LXEO icon
45
Lexeo Therapeutics
LXEO
$343M
$25.7M 0.72%
4,475,000
SLNO
46
DELISTED
Soleno Therapeutics
SLNO
$24.4M 0.68%
+730,000
BBNX
47
Beta Bionics
BBNX
$647M
$22.2M 0.62%
2,211,518
+1,611,518
NKTR icon
48
Nektar Therapeutics
NKTR
$2.01B
$20.5M 0.57%
+285,000
CYTK icon
49
Cytokinetics
CYTK
$9.52B
$19.8M 0.55%
+300,000
AZN icon
50
AstraZeneca
AZN
$277B
$19.7M 0.55%
+100,000
1
2
3 4 5